Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ledergerber

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Klinische Wochenschrift|March 16, 1987
Prevalence of HIV antibodies among prostitutes in Zürich, SwitzerlandR Lüthy, B Ledergerber, M Täuber, et al.
Sozial- Und Praventivmedizin|January 1, 1994
The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristicsB Ledergerber, J von Overbeck, M Egger, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996
Incidence of disseminated histoplasmosis in HIV-infected patients in SwitzerlandH C Bucher, K Gyr, B Ledergerber, et al.
Lancet (London, England)|February 24, 1999
Sex differences in HIV-1 viral load and progression to AIDS. Swiss HIV Cohort StudyC Junghans, B Ledergerber, P Chan, et al.
BMJ (Clinical Research Ed.)|December 15, 1990
Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadoneR Weber, B Ledergerber, M Opravil, et al.
Swiss Medical Weekly|April 12, 2014
Prevalence and risk factors of late presentation for HIV diagnosis and care in a tertiary referral centre in SwitzerlandS Buetikofer, G Wandeler, R Kouyos, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1985
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacinB Ledergerber, J D Bettex, B Joos, et al.
AIDS (London, England)|December 24, 1998
Levels of HIV-infected peripheral blood cells remain stable throughout the natural history of HIV-1 infection. Swiss HIV Cohort StudyR W Cone, P Gowland, M Opravil, et al.
Klinische Wochenschrift|March 2, 1987
Prevalence of HIV antibodies in groups at risk in Zürich, SwitzerlandJ Blaser, R Lüthy, S Rietiker, et al.
The European Respiratory Journal|February 1, 1996
Risk factors for tuberculosis among HIV-infected patients in Switzerland. Swiss HIV Cohort StudyP Sudre, B Hirschel, L Toscani, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Klinische Wochenschrift|March 16, 1987
Prevalence of HIV antibodies among prostitutes in Zürich, SwitzerlandR Lüthy, B Ledergerber, M Täuber, et al.
Sozial- Und Praventivmedizin|January 1, 1994
The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristicsB Ledergerber, J von Overbeck, M Egger, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996
Incidence of disseminated histoplasmosis in HIV-infected patients in SwitzerlandH C Bucher, K Gyr, B Ledergerber, et al.
Lancet (London, England)|February 24, 1999
Sex differences in HIV-1 viral load and progression to AIDS. Swiss HIV Cohort StudyC Junghans, B Ledergerber, P Chan, et al.
BMJ (Clinical Research Ed.)|December 15, 1990
Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadoneR Weber, B Ledergerber, M Opravil, et al.
Swiss Medical Weekly|April 12, 2014
Prevalence and risk factors of late presentation for HIV diagnosis and care in a tertiary referral centre in SwitzerlandS Buetikofer, G Wandeler, R Kouyos, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1985
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacinB Ledergerber, J D Bettex, B Joos, et al.
AIDS (London, England)|December 24, 1998
Levels of HIV-infected peripheral blood cells remain stable throughout the natural history of HIV-1 infection. Swiss HIV Cohort StudyR W Cone, P Gowland, M Opravil, et al.
Klinische Wochenschrift|March 2, 1987
Prevalence of HIV antibodies in groups at risk in Zürich, SwitzerlandJ Blaser, R Lüthy, S Rietiker, et al.
The European Respiratory Journal|February 1, 1996
Risk factors for tuberculosis among HIV-infected patients in Switzerland. Swiss HIV Cohort StudyP Sudre, B Hirschel, L Toscani, et al.
Pageof 12